Notice & Comment

Notice & Comment

Notice & Comment

The IRS’s Private Equity Regulations Might Backfire

In a post last week , my co-blogger Daniel Hemel explained how Section 707(a)(2)(A) may allow the IRS to deny the tax benefits associated with so-called carried interests, even in the absence of legislative action. That statute essentially grants the IRS the regulatory authority to alter the tax treatment of transactions between partners and partnerships, […]

Notice & Comment

A Guide to Judicial and Political Review of Federal Agencies, 2nd Ed. – The Ad Law Section’s Gift to Those of You Who May Have Forgotten to Grab Something for Mother’s Day, by Richard Murphy

Way back in 2005, one of the cosponsors of this blog, the Ad Law Section of the ABA, published A Guide to Judicial Review and Political Review of Federal Agencies , edited by Professors Michael Herz and John F. Duffy and featuring chapters by a murderers’ row of leading administrative law scholars. In addition to […]

Notice & Comment

Does Chevron Have An Immigration Exception?, by Michael Kagan

This morning, the Supreme Court announced its decision in Luna Torres v. Lynch, and it’s bad news if you are a non-citizen arsonist. The Court affirmed the Second Circuit, which had affirmed the Board of Immigration Appeals (BIA) decision that Jorge Luna Torres’ New York conviction for arson is an aggravated felony, making him deportable. […]

Notice & Comment

The Case for the Federal Reserve Banks’ Constitutionality is Uneasy Indeed, part II: Appointing and Removing the Reserve Bank Presidents

In my last post, I wrote about whether the Reserve Bank presidents were more like the CEO of the Girl Scouts or Warren Buffett on the one hand, or officers of the United States exercising significant government authority on the other. I think the answer is the latter, especially in light of how much authority […]

Notice & Comment

Don’t Panic About House v. Burwell, by Nicholas Bagley

Don’t panic about House v. Burwell. From the New York Times on what might happen if the House prevails in House v. Burwell: A study by the Department of Health and Human Services estimated that premiums for midlevel “silver plans” could rise by nearly 30 percent without [cost-sharing] reimbursements. Many consumers would be protected, since […]

Notice & Comment

D.C. Circuit Review – Reviewed: The Dissents that Matter Most to Chief Judge Garland, by Aaron Nielson

This week, Chief Judge Garland sent his questionnaire to the Senate. As I reviewed that “lengthy” submission, my mind turned again to “brooding spirts.” In particular, it is interesting that Garland’s list of his “most significant” opinions includes two dissents. To begin, here is Garland’s list: Cause of Action v. FTC (2015) Wagner v. FEC […]

Notice & Comment

A Government Defeat in House v. Burwell

Having previously held that the House of Representatives has standing to sue, the district court in House v. Burwell has now held that the Obama administration is violating the Appropriations Clause in making cost-sharing payments under the ACA in the absence of the requisite congressional appropriation. The court has stayed its decision pending appeal, meaning […]

Notice & Comment

Zika and Pregnancy-Specific Vaccines’ Regulatory Lacunae

In my next two posts, I will investigate the relationship between regulatory approval of vaccines and the response to the global public health emergency surrounding the spread of the Zika virus. That emergency has resurrected and brought into sharper relief some of the most vexing questions surrounding the regulatory state and pregnancy: the appropriate circumstances, […]

Notice & Comment

Eminent Domain for Drugs

From his perch at Politico, Dan Diamond has launched what promises to be a terrific new health-policy podcast, Pulse Check, with an interview with CMS’s acting administrator, Andy Slavitt. The interview is refreshingly candid: among other things, Slavitt confesses that the Obama administration has a lot of work to do to win back the hearts […]